Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Separated animal oil or solidified form thereof derived from...
Patent
1993-07-16
1995-07-11
Rollins, John W.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Separated animal oil or solidified form thereof derived from...
514825, A61K 4700
Patent
active
054319242
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
This invention relates to compositions for topical application that are useful for the treatment of musculoskeletal and dermatological conditions, in particular to composition based on emu oil and compounds that act to provide for its effective transdermal transport.
The invention further relates to methods for the treatment of the aforementioned conditions using these compositions.
The invention still further relates to compounds derived from emu oil which have anti-inflammatory properties.
For the purposes of this specification, the term "emu oil" refers to oils and preparations of oils derived from the emu (Dromais Novae--Hollandiae).
BACKGROUND ART
Within recent years there has been considerable interest in the role of the ingestion of polyunsaturated fatty acids in the prevention or treatment of arthritis, soft tissue inflammation and cardiovascular disease. This interest has arisen from the observation that Greenland Eskimos, on a traditional native diet, showed disease patterns quite different from age-matched individuals in Europe and North America. The most striking differences observed were the reduced incidence of heart disease, asthma, psoriasis and rheumatoid arthritis in Eskimo populations (1).
Examination of the Eskimo dietary lipid intake showed elevated levels of highly unsaturated fatty acids (HUFAs) arising from their high consumption of fish and marine, mammals. Subsequent clinical trials initiated by Kremer and co-workers (2) have demonstrated that the manipulation of the dietary intake of fatty acids to include higher levels of HUFAs in caucasian patients with rheumatoid arthritis could decrease the symptoms of arthritis.
The mechanism of action of this dietary intervention was considered, in part, to be dependent on the ability of the HUFAs to act as competitive substrates for enzymes involved in prostaglandin and leukotriene biosynthesis. Eicosapentaenoic acid (EPA) (20:5, n=3) and docosahexaenoic acid (22:6, n=3) are the principle long chain unsaturated fatty acid triglycerides in fish oil. EPA incorporated into cell membranes may be converted via the cyclooxygenase enzymes into the regulant prostaglandins, thromboxanes and prostacyclins of the 3-series (2-5) whereas PGE.sub.2 produced from arachidonic acid precursors was a potent mediator of inflammation. EPA metabolised via the lipoxygenase pathway produces leukotriene B5 (2-5). Leukotriene B5 is 10-30 times less potent an inflammogen than leukotriene B4 which is normally produced from arachidonic acid. Thus dietary fish oil supplementation may support endogenous anti-inflammatory activity by modifying the production of harmful mediators within the animal's tissues.
An alternative pathway of unsaturated fatty acid metabolism is via the C18-triunsaturated fatty acids, gamma and alpha linolenic acid. While the alpha isomer (9, 12, 15 octadecatrienoic acid) may be shunted into the prostaglandin E.sub.3 pathway, gamma linolenic acid (6, 9, 12 octadecatrienoic acid) is converted into dihomo-gamma-linolenic acid (DGLA) which is the biosynthetic precursor of the the anti-inflammatory prostaglandin E.sub.1 (PGE.sub.1) (6).
Evening primrose oil is also a rich source of gamma linolenic acid (7) and has been demonstrated to suppress chronic adjuvant induced polyarthritis in the rat (6) as well as in patients with rheumatoid arthritis (8).
There have been limited studies on the effects of administering these C18 unsaturated fatty acids topically for the treatment of inflammatory conditions.
In PCT/AU89/00555 (WO 90/07331) it is disclosed that linseed oil and other plant derived oils, which contain alpha linolenic acid, when dispersed in an appropriate solvent or thinner display topical anti-inflammatory activity. The specification goes on to disclose that the activity of this composition is thought to arise due to its alpha linolenic acid (9, 15, 15, octadecatrienoic acid) content. Suitable thinners, which in the context of the application mean compounds for increasing the transdermal transport of linseed oil, are
REFERENCES:
Pat. Abst of Japan C-20 p. 21 JP.A, 55-66514 (Sakurama)-May 5, 1988.
J. F. Blair "South Westerners Grow Emu, & Then Exotic Animals "Feedstuffs Jan. 28, 1990, p. 31.
O'Brien, et al., Proc. Aust. Soc Animal Prod. 18: 101-111, 1990.
Bennett, George, "Observations Pricipally on the Animal and Vegetable Productions of New South Wales, New Zealand," Gatherings of a Naturalist in Australasia, published London: John Van Voorst, Paternoster Row, pp. 216-219 (1860).
Leichhardt, L., "Journals, Lost and Found," Journal of an Overland Expedition in Australia, published London: T. W. Boone, pp. 388-389 (1847).
Naughton, Joan M., et al., "Animal Foods in Traditional Australian Aboriginal Diets: Polyunsaturated and Low in Fat," Lipids 21(11):684-690 (1986).
"Notes on the Field Sports and Fauna of Australia Felix," Bush Wanderings of a Naturalist, by an Old Bushman, published London: Routledge, Warne & Routledge (1861).
"Emu oil called a miracle," Sun p. 7 (Apr. 16, 1990.
Dawson Michael
Ghosh Peter
Turner Athol G.
Whitehouse Michael
Emu Products Western Australia Pty. Ltd.
Pabst Patrea L.
Rollins John W.
LandOfFree
Anti-inflammatory composition derived from emu oil does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory composition derived from emu oil, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory composition derived from emu oil will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-501873